ClariMed Inc. CEO Kelley Kendle Named Among Philadelphia's Elite Business Leaders in 2025 Titan 100

June 5, 2025

June 5, 2025

Chadds Ford, PA – June 5, 2025 - ClariMed, Inc., a global leader in human-centered medical device development and regulatory services, today announced that CEO Kelley Kendle has been named to the prestigious 2025 Philadelphia Titan 100, solidifying her position among the region's most influential business leaders. This recognition celebrates executives who are revolutionizing their industries through exceptional leadership, innovative vision, and unwavering passion.

The Titan 100 program, presented by Titan CEO and headline sponsor Wipfli LLP, represents companies generating over $145 billion in annual revenue and employing more than 111,000 people across the Philadelphia region, highlighting the significant economic impact of these visionary leaders.

"I'm honored to be recognized alongside such an accomplished group of Philadelphia business leaders," said Kendle. "This recognition reflects the incredible work of our entire ClariMed team and our commitment to revolutionizing how medical products are brought to market through human-centered design."

Under Kendle's leadership, ClariMed has experienced remarkable growth over the past three years, expanding to five global offices through strategic acquisitions, growing its team from 20 to 70 specialized consultants, and building state-of-the-art usability testing labs across all facilities. The company has evolved from a specialized consultancy to an end-to-end strategic partner for leading medical device manufacturers, growing its team from 20 to 70 specialized consultants and establishing state-of-the-art testing facilities that include specialized environments like operational surgical suites.

Kendle, who previously led Synchrogenix (a Certara subsidiary) from a single office with 15 employees to a multinational organization with 14 offices and over 350 employees, brings her philosophy that "Leadership is being the calm in storm and the beacon of light" to her role at ClariMed. She focuses on building people's careers and helping individuals recognize their talents while creating a work environment everyone wants to be part of.

Kelley Kendle and fellow honorees will be celebrated at the annual Titan 100 awards ceremony on September 18, 2025, at 2300 Arena in South Philadelphia.

Chadds Ford, PA – June 5, 2025 - ClariMed, Inc., a global leader in human-centered medical device development and regulatory services, today announced that CEO Kelley Kendle has been named to the prestigious 2025 Philadelphia Titan 100, solidifying her position among the region's most influential business leaders. This recognition celebrates executives who are revolutionizing their industries through exceptional leadership, innovative vision, and unwavering passion.

The Titan 100 program, presented by Titan CEO and headline sponsor Wipfli LLP, represents companies generating over $145 billion in annual revenue and employing more than 111,000 people across the Philadelphia region, highlighting the significant economic impact of these visionary leaders.

"I'm honored to be recognized alongside such an accomplished group of Philadelphia business leaders," said Kendle. "This recognition reflects the incredible work of our entire ClariMed team and our commitment to revolutionizing how medical products are brought to market through human-centered design."

Under Kendle's leadership, ClariMed has experienced remarkable growth over the past three years, expanding to five global offices through strategic acquisitions, growing its team from 20 to 70 specialized consultants, and building state-of-the-art usability testing labs across all facilities. The company has evolved from a specialized consultancy to an end-to-end strategic partner for leading medical device manufacturers, growing its team from 20 to 70 specialized consultants and establishing state-of-the-art testing facilities that include specialized environments like operational surgical suites.

Kendle, who previously led Synchrogenix (a Certara subsidiary) from a single office with 15 employees to a multinational organization with 14 offices and over 350 employees, brings her philosophy that "Leadership is being the calm in storm and the beacon of light" to her role at ClariMed. She focuses on building people's careers and helping individuals recognize their talents while creating a work environment everyone wants to be part of.

Kelley Kendle and fellow honorees will be celebrated at the annual Titan 100 awards ceremony on September 18, 2025, at 2300 Arena in South Philadelphia.

Let's work together!

We’re always looking for new opportunities. If you would like to partner with us, please get in touch.

Let's work together!

We’re always looking for new opportunities. If you would like to partner with us, please get in touch.

Let's work together!

We’re always looking for new opportunities. If you would like to partner with us, please get in touch.